Mountain Group Partners is an investor dedicated to investing in and actively guiding transformation businesses in the Life Science.
Business Model:
Revenue: $0
Employees: 0-0
Address: 3835 Cleghorn Ave
City: Nashville
State: TN
Zip: 37215
Country: US
Mountain Group Capital invests based on 4 core principles: Invest in the team first, idea second Invest based on business fundamentals, not financial engineering Invest as if you will own the business forever If possible, own the business forever
Contact Phone:
+16158439100
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2017 | Boragen | Series A | 10M |
5/2021 | MiNDERA Corporation | Series A | 0 |
5/2015 | Nusirt | Series C | 0 |
4/2015 | Contego Medical | Series B | 0 |
4/2010 | ONFocus Healthcare | Series B | 0 |
6/2012 | Nusirt | Seed Round | 600k |
3/2013 | American Hometown Media | Seed Round | 0 |
1/2013 | Streamweaver | Series A | 0 |
3/2012 | ONFocus Healthcare | Venture Round | 500k |
6/2012 | Pathfinder Technologies | Venture Round | 2.7M |
9/2012 | ABT Molecular Imaging | Series C | 6M |
9/2012 | Streamweaver | Seed Round | 650k |
1/2011 | Panopto | Venture Round | 4M |
12/2015 | ORIG3N | Series A | 0 |
9/2014 | Clearside Biomedical | Series B | 16M |
2/2015 | ORIG3N | Venture Round | 3.1M |
7/2022 | Verility | Series A | 3.5M |
12/2021 | Circular Genomics | Seed Round | 0 |
5/2021 | Advanced Animal Diagnostics | Series E | 0 |
4/2017 | NeuroTronik | Series B | 0 |
7/2018 | ORIG3N | Series B | 0 |
10/2013 | G1 Therapeutics | Series A | 0 |
2/2015 | G1 Therapeutics | Series B | 0 |
9/2018 | PhaseBio Pharmaceuticals | Series D | 0 |
3/2013 | Diagnovus | Seed Round | 60k |
12/2020 | Silicon Ranch | Private Equity Round | 0 |
11/2022 | Angel Eye Health | Series B | - |
8/2014 | Castle Biosciences | Venture Round | 11.8M |
3/2013 | Pathfinder Technologies | Seed Round | 200k |
1/2015 | Lineagen | Series C | 0 |
9/2013 | ABT Molecular Imaging | Venture Round | 1M |
5/2022 | TARGAN | Series C | 0 |
6/2013 | Diagnovus | Seed Round | 100k |
1/2023 | Silicon Ranch | Private Equity Round | 375M |
7/2015 | MedCenterDisplay | Series B | 0 |
6/2018 | Appello Pharmaceuticals | Series A | 15.5M |
5/2012 | Diabetes Care Group | Venture Round | 0 |
5/2016 | G1 Therapeutics | Series C | 0 |
9/2012 | Diagnovus | Seed Round | 100k |
3/2012 | Pathfinder Technologies | Seed Round | 250k |
1/2022 | Silicon Ranch | Private Equity Round | 0 |
3/2014 | Nusirt | Series A | 0 |
6/2014 | Nusirt | Series B | 1.8M |
10/2011 | Industrial Ceramic Solutions | Seed Round | 1.1M |
9/2013 | Diagnovus | Seed Round | 250k |
10/2011 | Diagnovus | Seed Round | - |
5/2015 | Myomo | Series B | 5M |
6/2012 | MedCenterDisplay | Seed Round | 3.1M |
6/2014 | InvisionHeart | Series A | 1.9M |
5/2021 | TARGAN | Series B | 0 |
3/2019 | TARGAN | Series A | 0 |
8/2014 | MedCenterDisplay | Series B | 0 |
7/2015 | Restore Medical Solutions | Series A | 0 |
9/2013 | Streamweaver | Series A | 0 |
11/2013 | Diagnovus | Seed Round | 1.5M |
6/2013 | Pathfinder Technologies | Venture Round | 1.2M |
12/2015 | splitsecnd | Venture Round | 6.3M |
6/2012 | SwingPal | Seed Round | 625k |
3/2013 | SwingPal | Seed Round | 125k |
9/2013 | SwingPal | Seed Round | 50k |
11/2019 | AN2 Therapeutics | Series A | 0 |
7/2022 | Verility | Series A | 0 |
5/2022 | TARGAN | Series C | 0 |
1/2022 | Silicon Ranch | Private Equity Round | 0 |
12/2021 | Circular Genomics | Seed Round | 0 |
5/2021 | TARGAN | Series B | 0 |
5/2021 | MiNDERA Corporation | Series A | 0 |
5/2021 | Advanced Animal Diagnostics | Series E | 0 |
12/2020 | Silicon Ranch | Private Equity Round | 0 |
11/2019 | AN2 Therapeutics | Series A | 0 |
3/2019 | TARGAN | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|